Skip to main content

MEI Pharma Inc

For the period ended Jun 30, 2024. Filed Sep 19, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Sep 19, 2024

LITS$0.96+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 14. Principal Accountant Fees and Services

The Audit Committee has selected Deloitte & Touche LLP (Deloitte) as independent registered public accounting firm to audit the financial statements of MEI for the fiscal year ending June 30, 2025. The Board is submitting the appointment of Deloitte to the stockholders for ratification as a matter of good corporate practice.

Representatives of Deloitte are expected to attend the Annual Meeting. The Deloitte representatives will have an opportunity to make a statement at the meeting and are expected to be available to respond to appropriate questions.

Fees Paid to Independent Registered Public Accounting Firm

Our independent registered public accounting firm is Deloitte & Touche LLP (Deloitte) Auditor Firm ID: 34.

BDO USA, P.C. (BDO) served as the independent registered public accounting firm for us for the period from January 18, 2011 through the fiscal year ended June 30, 2023 and the subsequent interim period ended September 30, 2023. On December 19, 2023 our Audit Committee approved the change in our independent registered public accounting firm effective December 26, 2023 to Deloitte.

The following table represents the aggregate fees from our principal accounting firm, Deloitte for the fiscal year ended June 30, 2024 and our former principal accounting firm, BDO, for the fiscal year ended June 30, 2023.

DeloitteBDO
June 30, 2024June 30, 2023
Audit Fees (1)$528,525$806,100
Audit-Related Fees——
Tax Fees (2)—76,580
All Other Fees——
Total Fees$528,525$882,680

(1)

Audit Fees relate to professional services rendered in connection with the audit of our annual consolidated financial statements, quarterly review of consolidated financial statements included in our Quarterly Reports on Form 10-Q and audit services provided in connection with other statutory and regulatory filings, including providing consents for inclusion of their opinion in registration statements filed with the Securities and Exchange Commission, and comfort letters in connection with sales of securities. During the fiscal year ended June 30, 2023, Audit Fees include $122,525 of fees related to the proposed Merger transaction.

(2)

Tax Fees consist of fees for professional services related to tax compliance and advice. During 2023, Tax Fees include $51,200 of tax due diligence fees related to the proposed Merger transaction.

Pre-Approval Policies and Procedures

The Audit Committee has adopted a policy and procedure for pre-approving all audit and non-audit services to be performed by our independent auditors. The policy requires pre-approval of all services rendered by our independent auditors either as part of the Audit Committee’s approval of the scope of the engagement of the independent auditors or on a case-by-case basis.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.